Inclisiran is a PCSK9 inhibitor used to lower LDL cholesterol levels in patients with hyperlipidemia. It works by blocking PCSK9, increasing LDL receptor availability and promoting cholesterol clearance. This medication is crucial for managing cholesterol levels. In summary, Inclisiran is effective in lowering LDL cholesterol.
Inclisiran inhibits PCSK9, enhancing LDL receptor recycling and decreasing LDL cholesterol levels.